Skip to main content
SpringerLink
Log in

Raised HDL cholesterol in Fabry disease: Response to enzyme replacement therapy

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Fabry disease patients have increased risk of vascular disease despite cardioprotective increased HDL-cholesterol. Enzyme therapy does not significantly alter the lipid profile in the short term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  • Desnick RJ, Ioannou YA, Eng CM(2001)α-Galactosidase A deficiency:Fabry disease (2001). In:Scriver CR, Beaudet AL, Sly WS, Valle,D,eds;Childs B, Kinzler KW, Vogelstein B, assoc.eds.The Metabolic and Molecular Bases of Inherited Disease,8th edn.New York: McGraw-Hill,3733-3774.

    Google Scholar 

  • Eng CM, Guffon N, Wilcox WR,et al (2001)Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry 's disease.N Engl J Med 345:9-16.

    Google Scholar 

  • Sacks FM (2002)The role of high density lipoprotein cholesterol in the prevention and treatment of coronary heart disease:expert group recommendations.Am J Cardiol 90:139-142.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK

    D. J. Cartwright, A. L. Cole, A. J. Cousins & P. J. Lee

Authors
  1. D. J. Cartwright
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. L. Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. J. Cousins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. J. Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cartwright, D.J., Cole, A.L., Cousins, A.J. et al. Raised HDL cholesterol in Fabry disease: Response to enzyme replacement therapy. J Inherit Metab Dis 27, 791–793 (2004). https://doi.org/10.1023/B:BOLI.0000045841.27968.06

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000045841.27968.06

Search

Navigation